EUVIMEDEUVIMED entdecken
Kohortenstudie

First‐trimester fasting plasma glucose levels and progression to type 2 diabetes: A 5‐year cohort study

Esther Maor-Sagie iD, Mordechai Hallak, Gilad Twig, Yoel Toledano, Rinat Gabbay-Benziv iD

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15727 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Esther Maor-Sagie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Haifa, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Pregnancy Trimester, First, Blood Glucose, Diabetes, Gestational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Impaired fasting glucose is a prediabetic condition defined as glucose levels of 100–125 mg/dL and is considered a risk factor for type 2 diabetes. However, this definition does not confer to pregnancy. The significance of first‐trimester fasting glucose and future progression to diabetes is not well defined. Therefore, we aimed to evaluate the progression to type 2 diabetes according to first‐ trimester fasting plasma glucose levels, as compared with gestational diabetes, a well‐established risk factor for diabetes, in up to 5‐year follow‐up postpartum.

Methods

A retrospective analysis of 69 001 parturients, evaluating fasting plasma glucose levels measured during the first trimester. The primary outcome was the incidence of type 2 diabetes within 5 years post‐delivery. Fasting plasma glucose levels were categorized in 10 mg/dL increments. Receiver operating characteristic‐area under the curve (ROC‐AUC) statistics and the Youden index were employed to identify the optimal fasting plasma glucose cutoff for progression to type 2 diabetes. Survival analysis was applied to calculate the adjusted hazard ratios (aHRs) for type 2 diabetes progression with further stratification to maternal obesity status.

Results

The identified fasting plasma glucose cutoff for progression to type 2 diabetes was 86.5 mg/dL. This cut‐off demonstrated superior performance compared with gestational diabetes diagnosis. Stratification by maternal obesity revealed enhanced predictive capabilities for type 2 diabetes, particularly among patients without obesity.

Conclusions

Increased first‐trimester fasting plasma glucose levels are associated with progression to type 2 diabetes, at least as gestational diabetes. For patients without obesity, first‐trimester fasting plasma glucose has a more pronounced impact on progression to diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Pregnancy Trimester, FirstBlood GlucoseDiabetes, GestationalDisease ProgressionFastingHumansFemalePregnancyAdultRetrospective StudiesRisk FactorsPrediabetic StateIncidence

Stichwörter der Autor:innen

fasting plasma glucosegestational diabetes mellituspregnancyprogressiontype 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Haifa, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel.
  • Meuhedet HMO, Meuhedet Health Services, Tel Aviv, Israel.
  • Institute of Endocrinology, Diabetes and Metabolism and The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Ramat Gan, Israel.
  • Department of Preventive Medicine and Epidemiology, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Esther Maor-Sagie, Rinat Gabbay-Benziv

Zitieren

APA

Maor-Sagie, E., Hallak, M., Twig, G., Toledano, Y., & Gabbay-Benziv, R. (2024). First‐trimester fasting plasma glucose levels and progression to type 2 diabetes: A 5‐year cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15727

Vancouver

Maor-Sagie E, Hallak M, Twig G, Toledano Y, Gabbay-Benziv R. First‐trimester fasting plasma glucose levels and progression to type 2 diabetes: A 5‐year cohort study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15727

BibTeX
@article{MaorSagie2024,
  author = {Maor-Sagie, Esther and Hallak, Mordechai and Twig, Gilad and Toledano, Yoel and Gabbay-Benziv, Rinat},
  title = {First‐trimester fasting plasma glucose levels and progression to type 2 diabetes: A 5‐year cohort study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15727}
}
Kostenlos starten →